Genetic and molecular genetic studies in the diagnosis of B-cell lymphomas I: Mantle cell lymphoma, follicular lymphoma, and Burkitt's lymphoma

Human Pathology

Volumn 34, Issue 4, 2003, Pages 330-335

  Campo, Elias ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN G1; CYCLINE; LEUKOSIALIN; PROTEIN BCL 2; PROTEIN P15; PROTEIN P16; PROTEIN P53; UNCLASSIFIED DRUG;

B CELL LYMPHOMA; BLAST CELL; BURKITT LYMPHOMA; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; CONFERENCE PAPER; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE AMPLIFICATION; GENE REARRANGEMENT; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MANTLE CELL LYMPHOMA; MOLECULAR GENETICS; NORTHERN BLOTTING; ONCOGENE C MYC; PLOIDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0038415981     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2003.97     Document Type: Conference Paper

References (55)

1. Campo E, Raffeld M, Jaffe ES: Mantle-cell lymphoma. Semin Hematol 36:115-127, 1999
2. Swerdlow SH, Williams ME: From centrocytic to mantle cell lymphoma: A clinicopathologic and molecular review of 3 decades. HUM PATHOL 33:7-20, 2002
3. Vadlamudi G, Lionetti KA, Greenberg S, et al: Leukemic phase of mantle cell lymphoma: Two case reports and review of the literature. Arch Pathol Lab Med 120:3540, 1996
4. Majlis A, Pugh WC, Rodriguez MA, et al: Mantle cell lymphoma: Correlation of clinical outcome and biologic features with three histologic variants. J Clin Oncol 15:1664-1671, 1997
5. Weisenburger D, Kim H, Rappaport H: Mantle zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma. Cancer 49:1429-1438, 1982
6. Bosch F, Jares P, Campo E, et al: PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma. Blood 84:2726-2732, 1994
7. de Boer CJ, van Krieken JHJM, Kluin-Nelemans HC, et al: Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 10:1833-1840, 1995
8. Ott MM, Helbing A, Ott G, et al: Bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol 179:238-242, 1996
9. Chan JK, Miller KD, Munson P, et al: Immunostaining for cyclin D1 and the diagnosis of mantle cell lymphoma: Is there a reliable method? Histopathology 34:266-270, 1999
10. Miranda RN, Briggs RC, Kinney MC, et al: Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia. Mod Pathol 13:1308-1314, 2000
11. Uchimaru K, Taniguchi T, Yoshikawa M, et al: Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11; 14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Blood 89:965-974, 1997
12. Athanasiou E, Kotoula V, Hytiroglou P, et al: In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mande cell lymphoma in paraffinembedded tissues. Mod Pathol 14:62-71, 2001
13. Bijwaard KE, Aguilera NS, Monczak Y, et al: Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: Utility in the diagnosis of mande cell lymphoma. Clin Chem 47:195-201, 2001
14. Suzuki R, Takemura K, Tsutsumi M, et al: Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma. Am J Pathol 159:425-429, 2001
15. Elnenaei MO, Jadayel DM, Matutes E, et al: Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies. Leuk Res 25:115-123, 2001
16. Yang WI, Zukerberg LR, Motokura T, et al: Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 145:86-96, 1994
17. Pruneri G, Fabris S, Baldini L, et al. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14). Am J Pathol 156:1505-1513, 2000
18. Hoechtlen-Vollmar W, Menzel G, Bartl R, et al: Amplification of cyclin D1 gene in multiple myeloma: Clinical and prognostic relevance. Br J Haematol 109:30-38, 2000
19. Bosch F, Campo E, Jares P, et al: Increased expression of the PRAD-1/CCND1 gene in hairy cell leukemia. Br J Haematol 91:1025-1030, 1995
20. de Boer CJ, Kluin-Nelemans JC, Dreef E, et al: Involvement of the CCND1 gene in hairy cell leukemia. Ann Oncol 7:251-256, 1996
21. Pinyol M, Campo E, Nadal A, et al: Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction. Am J Clin Pathol 105:532-537, 1996
22. Kumar S, Krenacs L, Otsuki T, et al: Bcl-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis. Am J Clin Pathol 105:737-743, 1996
23. Bohling SD, Wittwer CT, King TC, et al: Fluorescence melting curve analysis for the detection of the bcl-1/JH translocation in mantle cell lymphoma. Lab Invest 79:337-345, 1999
24. Luthra R, Sarris AH, Hai S, et al: Real-time 5′->3′ exonuclease-based PCR assay for detection of the t(11;14)(q13;q32). Am J Clin Pathol 112:524-530, 1999
25. Vasef MA, Medeiros LJ, Koo C, et al: Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow. Am J Clin Pathol 108:302-307, 1997
26. Yatabe Y, Suzuki R, Tobinai K, et al: Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: A clinico-pathologic comparison of cyclin Dl-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 95:2253-2261, 2000
27. Ott G, Kalla J, Ott MM, et al: Blastoid variants of mande cell lymphoma: Frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood 89:1421-1429, 1997
28. Bosch F, Lopez-Guillermo A, Campo E, et al: Mande cell lymphoma: Presenting features, response to therapy, and prognostic factors. Cancer 82:567-575, 1998
29. Bea S, Ribas M, Hernandez JM, et al: Increased number of chromosomal imbalances and high-level DNA amplifications in mande cell lymphoma are associated with blastoid variants. Blood 93: 4365-4374, 1999
30. Tirier C, Zhang Y, Plendl H, et al: Simultaneous presence of t(11;14) and a variant Burkitt's translocation in the terminal phase of a mantle cell lymphoma. Leukemia 10:346-350, 1996
31. Au AY, Horsman DE, Viswanatha DS, et al: 8q24 translocations in blastic transformation of mande cell lymphoma. Haematologica 85:1225-1227, 2000
32. Jares P, Campo E, Pinyol M, et al: Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. Am J Pathol 148:1591-1600, 1996
33. Ott MM, Bartkova J, Bartek J, et al: Cyclin D1 expression in mande cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity. Blood 90:3154-3159, 1997
34. Neilson JR, Fegan CD, Milligan DW: Mantle cell leukaemia? [letter]. Br J Haematol 93:494-495, 1996
35. Dascalescu C, Gressin R, Callanan M, et al: t(11;14)(q13; q32): Chronic lymphocytic leukaemia or mantle cell leukaemia? [letter]. Br J Haematol 95:572-573, 1996
36. Schlette E, Bueso-Ramos C, Giles F, et al: Mature B-cell leukemias with more than 55% prolymphocytes: A heterogeneous group that includes an unusual variant of mande cell lymphoma. Am J Clin Pathol 115:571-581, 2001
37. De Angeli C, Gandini D, Cuneo A, et al: Bcl-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32). Haematologica 85:913-921, 2000
38. Levy V, Ugo V, Delmer A, et al: Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder. Leukemia 13:1343-1351, 1999
39. Schlette E, Lai R, Onciu M, et al: Leukemic mantle cell lymphoma: Clinical and pathologic spectrum of twenty-three cases. Mod Pathol 14:1133-1140, 2001
40. Martinez-Climent JA, Vizcarra E, Sanchez D, et al: Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma. Blood 98:3479-3482, 2001
41. Onciu M, Schlette E, Medeiros LJ, et al: Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities. Am J Clin Pathol 116:886-892, 2001
42. Hofmann WK, de Vos S, Tsukasaki K, et al: Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood 98:787-794, 2001
43. Pinto A, Hutchison RE, Grant LH, et al: Follicular lymphomas in pediatric patients. Mod Pathol 3:308-313, 1990
44. Ribeiro RC, Pui CH, Murphy SB, et al: Childhood malignant non-Hodgkin lymphomas of uncommon histology. Leukemia 6:761-765, 1992
45. Atra A, Meller ST, Stevens RS, et al: Conservative management of follicular non-Hodgkin's lymphoma in childhood. Br J Haematol 103:220-223, 1998
46. Jaffe ES, Harris NL, Stein H, et al (eds): World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC Press, 2001
47. Leith CP, Willman CL, Spier CM, et al: The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma: A disease with diverse molecular and immunophenotypic findings. Diagn Mol Pathol 3:178-183, 1994
48. Oviatt DL, Cousar JB, Collins RD, et al: Malignant lymphomas of follicular center cell origin in humans. V. Incidence, clinical features, and prognostic implications of transformation of small cleaved cell nodular lymphoma. Cancer 53:1109-1114, 1984
49. Gallagher CJ, Gregory WM, Jones AE, et al: Follicular lymphoma: Prognostic factors for response and survival. J Clin Oncol 4:1470-1480, 1986
50. Yano T, Jaffe ES, Longo DL, et al: MYC rearrangements in histologically progressed follicular lymphomas. Blood 80:758-767, 1992
51. Sander CA,Yano T, Clark HM, et al: p53 mutation is associated with progression in follicular lymphomas. Blood 82:1994-2004, 1993
52. Elenitoba-Johnson KS, Gascoyne RD, Lim MS, et al: Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 91:4677-4685, 1998
53. DeJong D, Voetdijk BM, Beverstock GC, et al: Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med 318: 1373-1378, 1998
54. Kramer MH, Hermans J, Wijburg E, et al: Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 92:3152-3162, 1998
55. Rosenwald A, Wright G, Wiestner A, et al: The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantel cell lymphoma. Cancer Cell 3:185-197, 2003